Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

After a 20% cut to the FDA’s workforce, biotechs and pharmas are bracing for delays. But the impacts won’t be consistent.

The FDA has discussed with vaccine-maker Novavax the need for an additional trial of its COVID-19 vaccine as a post-approval ...

Novavax, Inc. (NVAX) shares jumped nearly 12.6% over the past week, leading to a surge in retail investor chatter following ...

Former National Institutes of Health Director Dr. Francis Collins, who abruptly left his NIH research lab in February, fears ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...

Rep. Jacob Banta said in the bill's memo that Ivermectin is "a very safe drug that has been used by millions of people ...

Andreas Kalcker’s appearance at the conference highlights how dangerous alternative health claims have been growing during Trump’s second term in office.